Osteoarthritis, Knee Clinical Trial
Official title:
The Functional Treatment of Disabling Pain in Knee Osteoarthritis in a Rehabilitation Program for the Brazilian Unified Health System
This is a Randomized Clinical Trial to compare two interventions for reducing knee pain and improving knee function of patients with knee osteoarthritis. Sixty participants will be randomly allocated to one of the intervention groups, either a knee educational program or a combination of knee educational program and medical interventions. Participants will be assessed primarily on function and pain, as well as other secondary outcomes at baseline, at the end of the interventions, and three months after the end of the interventions.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | November 30, 2024 |
Est. primary completion date | November 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years and older |
Eligibility | Inclusion Criteria: - Clinical diagnosis of knee osteoarthritis; - Moderate to severe knee pain (VAS >= 4); - Knee pain for at least 3 months prior to inclusion; - Willing to sign the Informed Consent Form. Exclusion Criteria: - Untreated severe psychological or psychiatric diseases without treatment; - Presence of fibromyalgia; - Presence of systemic inflammatory rheumatic diseases; - Presence of neoplasia; - Presence of relevant pain in other joints, according to medical evaluation; - Presence of intolerance or allergy to Lidocaine or local anaesthetics; - Concomitant use of anticoagulant drug. |
Country | Name | City | State |
---|---|---|---|
Brazil | Instituto de Medicina Física e Reabilitação (IMREA-FMUSP) | São Paulo |
Lead Sponsor | Collaborator |
---|---|
Marta Imamura | Ministry of Health, Brazil |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Nutritional status | Nutritional status scale | Baseline | |
Other | Body Mass Index | Body Mass Index (BMI): the ratio of weight divided by the squared height. | Baseline | |
Other | Cognitive status | Cognitive status measured with Montreal Cognitive Assessment Test (MoCA) | Baseline | |
Other | Electroencephalogram (EEG) | Change from baseline of neurophysiological parameters with an EEG system. The analyzed parameters will be absolute power (µV2) and relative power (power in a specific frequency range/total power from 1 to 40 Hz) for the frequency bands delta (1-4 Hz), theta (4-8 Hz), alpha (8-13 Hz), beta (13-30 Hz), and the sub-bands: low beta (13-20 Hz) and high beta (20-30 Hz), measured at the central, parietal, and frontal areas. | Baseline, up to three months from baseline, and up to six months from baseline. | |
Other | Magnetic Resonance Imaging (MRI) | Magnetic resonance imaging of the knees | Baseline | |
Other | Demography | Demographic characteristics of participants, such as age, sex, schooling, body mass index (BMI), concomitant medical drug use, and comorbidities. | Baseline | |
Primary | Knee function | Change of knee function from baseline measured with Knee Injury and Osteoarthritis Outcome Score (KOOS) | Baseline and up to six months from baseline. | |
Secondary | Knee function | Change of knee function from baseline measured with Knee Injury and Osteoarthritis Outcome Score (KOOS) | Baseline and up to three months from baseline. | |
Secondary | Knee pain as assessed by Visual Analogue Scale (VAS) | Change of knee pain from baseline measured with Visual Analogue Scale (VAS), a 0 - 10 rating scale in which 0 means no pain and 10 means the worst pain possible. | Baseline, up to three months from baseline, and up to six months from baseline. | |
Secondary | Quality of Life Assessment as assessed by the 36-Item Short-Form Health Survey (SF-36) | Change of Quality of Life from baseline measured with the 36-Item Short-Form Health Survey (SF-36) | Baseline, up to three months from baseline, and up to six months from baseline. | |
Secondary | Physical activity level | Change of classification of physical activity level according to a physical activity level scale | Baseline, up to three months from baseline, and up to six months from baseline. | |
Secondary | Pain pressure threshold | Change of pain pressure threshold measured bilaterally with an algometer, at vastus medialis, adductor longus, rectus femoris, vastus lateralis, tibialis anterior, peroneus longus, iliacus, sartorius, gracilis, quadratus lumborum, popliteus, and ligaments located over the supraspinous ligaments between L1-L2, L2-L3, L3-L4, L4-L5, L5-S1 and sacral (S) areas S1-S2. | Baseline, end of treatment, and three months from end of treatment. | |
Secondary | Pain modulation | Change of conditioned pain modulation test of hands in cold water | Baseline, up to three months from baseline, and up to six months from baseline. | |
Secondary | Bio-mechanical assessment (Steps) | Change of bio-mechanic variables, assessment with a wearable three axial accelerometer. The patients will wear an accelerometer (Actigraph) for one week before all evaluation time points. Daily data on number of steps will be collected. | Baseline, up to three months from baseline, and up to six months from baseline. | |
Secondary | Bio-mechanical assessment (Energy Expenditure) | Change of bio-mechanic variables, assessment with a wearable three axial accelerometer. The patients will wear an accelerometer (Actigraph) for one week before all evaluation time points. Daily data on energy expenditure (kcal) will be collected. | Baseline, up to three months from baseline, and up to six months from baseline. | |
Secondary | Bio-mechanical assessment (Physical activity intensity) | Change of bio-mechanic variables, assessment with a wearable three axial accelerometer. The patients will wear an accelerometer (Actigraph) for one week before all evaluation time points. Daily data on physical activity intensity will be collected. | Baseline, up to three months from baseline, and up to six months from baseline. | |
Secondary | Bio-mechanical assessment (Step velocity) | Change of bio-mechanic variables, assessment with a wearable three axial accelerometer. The patients will wear an accelerometer (Actigraph) for one week before all evaluation time points. Daily data on step velocity (steps/second) will be collected. | Baseline, up to three months from baseline, and up to six months from baseline. | |
Secondary | Gait analysis (gait cycle) | Change of gait parameters measured by a three-dimensional gait analysis system in a gait analysis lab. Ten Infra-red cameras will detect gait parameters and a platform will detect the different pressures delivered by both lower limbs during gait. Bilateral gait cycle (seconds) will be collected, compared and analyzed. | Baseline and up to three months from baseline. | |
Secondary | Gait analysis (joint angles) | Change of gait parameters measured by a three-dimensional gait analysis system in a gait analysis lab. Ten Infra-red cameras will detect gait parameters and a platform will detect the different pressures delivered by both lower limbs during gait. Bilateral joint angles (degrees) will be collected and analyzed. | Baseline and up to three months from baseline. | |
Secondary | Muscle strength (Work) | Change in muscle strength (knee flexion and extension) measured by an isokinetic dynamometry (Cybex), at 60º and 120º per second. The analyzed variables will be work (Joules - J). | Baseline, up to three months from baseline, and up to six months from baseline. | |
Secondary | Muscle strength (Power) | Change in muscle strength (knee flexion and extension) measured by an isokinetic dynamometry (Cybex), at 60º and 120º per second. The analyzed variables will be Power (Watts - W). | Baseline, up to three months from baseline, and up to six months from baseline. | |
Secondary | Muscle strength (Peak torque) | Change in muscle strength (knee flexion and extension) measured by an isokinetic dynamometry (Cybex), at 60º and 120º per second. The analyzed variables will be bilateral Peak tork (Newton meters - Nm). | Baseline, up to three months from baseline, and up to six months from baseline. | |
Secondary | Muscle strength (Agonist/Antagonist Balance) | Change in muscle strength (knee flexion and extension) measured by an isokinetic dynamometry (Cybex), at 60º and 120º per second. The analyzed variables will be agonist/antagonist balance of knee flexion and extension (difference of strength between agonist/antagonist in %). | Baseline, up to three months from baseline, and up to six months from baseline. | |
Secondary | Functional mobility | Change in functional mobility measured with the Timed Up and Go test (TUG) | Baseline, up to three months from baseline, and up to six months from baseline. | |
Secondary | Cutaneous temperature | Change in cutaneous temperature of the knee with Infra-red thermography images. | Baseline, up to three months from baseline, and up to six months from baseline. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03895489 -
Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses
|
N/A | |
Completed |
NCT03660943 -
A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain
|
Phase 3 | |
Completed |
NCT04531969 -
Comparison of Outpatient and Inpatient Spa Therapy
|
N/A | |
Completed |
NCT02848027 -
Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment
|
Phase 3 | |
Completed |
NCT05160246 -
The Instant Effect of Kinesiology Taping in Patients With Knee OA
|
N/A | |
Recruiting |
NCT06080763 -
Biomechanics and Clinical Outcomes in Responders and Non-Responders
|
||
Completed |
NCT03643588 -
The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain
|
N/A | |
Active, not recruiting |
NCT05100225 -
Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis
|
Phase 2 | |
Active, not recruiting |
NCT04061733 -
New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis
|
N/A | |
Completed |
NCT04051489 -
A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
|
||
Recruiting |
NCT05546541 -
Epidemiology and Nutrition
|
||
Recruiting |
NCT05447767 -
Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg
|
Phase 2 | |
Not yet recruiting |
NCT04448106 -
Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis
|
Phase 2 | |
Not yet recruiting |
NCT03225911 -
Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis
|
N/A | |
Completed |
NCT05070871 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women
|
N/A | |
Completed |
NCT05703087 -
Positive Cueing in Knee Arthroplasty.
|
N/A | |
Not yet recruiting |
NCT06042426 -
Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population
|
Phase 4 | |
Completed |
NCT02901964 -
Effect of Strengthening the Hip Abductor in Patients With Knee Osteoarthritis: Randomized Controlled Trial
|
N/A | |
Not yet recruiting |
NCT02865174 -
Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty
|
Phase 4 | |
Completed |
NCT02881775 -
Immediate Effects of rTMS on Excitability of the Quadriceps With Knee Osteoarthritis
|
N/A |